Cargando…
IBD in the time of corona — vigilance for immune-mediated diseases
The gastrointestinal tract represents a target organ for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), warranting a thorough discussion on the consequences, particularly regarding inflammatory bowel diseases. Here, aspects of gastrointestinal involvement with SARS-CoV-2, the role of...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301345/ https://www.ncbi.nlm.nih.gov/pubmed/32555385 http://dx.doi.org/10.1038/s41575-020-0333-5 |
| _version_ | 1783547670639411200 |
|---|---|
| author | Moschen, Alexander R. |
| author_facet | Moschen, Alexander R. |
| author_sort | Moschen, Alexander R. |
| collection | PubMed |
| description | The gastrointestinal tract represents a target organ for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), warranting a thorough discussion on the consequences, particularly regarding inflammatory bowel diseases. Here, aspects of gastrointestinal involvement with SARS-CoV-2, the role of viruses as modulators of mucosal immunity and as treatment-related safety hazards, and the current clinical evidence will be discussed. |
| format | Online Article Text |
| id | pubmed-7301345 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73013452020-06-18 IBD in the time of corona — vigilance for immune-mediated diseases Moschen, Alexander R. Nat Rev Gastroenterol Hepatol Comment The gastrointestinal tract represents a target organ for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), warranting a thorough discussion on the consequences, particularly regarding inflammatory bowel diseases. Here, aspects of gastrointestinal involvement with SARS-CoV-2, the role of viruses as modulators of mucosal immunity and as treatment-related safety hazards, and the current clinical evidence will be discussed. Nature Publishing Group UK 2020-06-18 2020 /pmc/articles/PMC7301345/ /pubmed/32555385 http://dx.doi.org/10.1038/s41575-020-0333-5 Text en © Springer Nature Limited 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Comment Moschen, Alexander R. IBD in the time of corona — vigilance for immune-mediated diseases |
| title | IBD in the time of corona — vigilance for immune-mediated diseases |
| title_full | IBD in the time of corona — vigilance for immune-mediated diseases |
| title_fullStr | IBD in the time of corona — vigilance for immune-mediated diseases |
| title_full_unstemmed | IBD in the time of corona — vigilance for immune-mediated diseases |
| title_short | IBD in the time of corona — vigilance for immune-mediated diseases |
| title_sort | ibd in the time of corona — vigilance for immune-mediated diseases |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301345/ https://www.ncbi.nlm.nih.gov/pubmed/32555385 http://dx.doi.org/10.1038/s41575-020-0333-5 |
| work_keys_str_mv | AT moschenalexanderr ibdinthetimeofcoronavigilanceforimmunemediateddiseases |